Transmarket Holdings »

Esperion Therapeutics shares owned by Transmarket Holdings

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Transmarket Holdings from 13F filings

Historical chart of Transmarket Holdings investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Transmarket Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Transmarket Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0M 1.6M 3.16

More positions owned by Transmarket Holdings

Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Spdr Series Trust St Sho Treas Etf (SPTS)
GSK Sponsored Adr (GSK)
Nuvalent Inc-a (NUVL)
Ing Groep Sponsored Adr (ING)
Sila Realty Trust Common Stock
Liberty Broadband Corp Com Ser A (LBRDA)
Natwest Group Spons Adr (NWG)
Open Lending Corp (LPRO)
Rio Tinto Sponsored Adr (RIO)
BP Sponsored Adr (BP)
Esperion Therapeutics (ESPR)
Whitestone REIT (WSR)
Novo-nordisk A S Adr (NVO)
Computer Programs & Systems (TBRG)

View all positions for Transmarket Holdings

Top funds holding Esperion Therapeutics

Glazer Capital
BlackRock
Vanguard Capital Management
Trium Capital
Goldman Sachs Group
Two Sigma Investments
State Street Corporation
Geode Capital Management
CNH Partners
Oddo Bhf Asset Management Sas
Balyasny Asset Management
FMR
Beryl Capital Management
PenderFund Capital Management
UBS Group

View all funds holding Esperion Therapeutics